Lemsip Cough Max for Mucus Cough & Cold 500mg/100mg/6.1mg capsules

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

유효 성분:

Paracetamol; Phenylephrine hydrochloride; Guaifenesin

제공처:

Reckitt Benckiser Healthcare (UK) Ltd

ATC 코드:

N02BE51

INN (국제 이름):

Paracetamol; Phenylephrine hydrochloride; Guaifenesin

복용량:

500mg ; 6.1mg ; 100mg

약제 형태:

Oral capsule

관리 경로:

Oral

수업:

No Controlled Drug Status

처방전 유형:

Never Valid To Prescribe As A VMP

제품 요약:

BNF: ; GTIN: 5000158069169

환자 정보 전단

Reckitt Benckiser
Lemsip All In one DCP capsules 0211405 amendment
1.3.2 Mock-up
Lemsip All In one DCP capsules 0211405
Page 4

제품 특성 요약

OBJECT 1
LEMSIP COUGH MAX FOR MUCUS COUGH & COLD
500MG/100MG/6.1MG CAPSULES
Summary of Product Characteristics Updated 23-Oct-2017 | Reckitt
Benckiser Healthcare (UK) Ltd
1. Name of the medicinal product
Lemsip Max All in One Cold & Flu Capsules
Lemsip Cough Max for Mucus Cough & Cold 500mg/100mg/6.1mg Capsules
2. Qualitative and quantitative composition
Each capsule contains paracetamol 500mg, phenylephrine hydrochloride
6.1mg and guaifenesin 100mg
For a full list of excipients, see Section 6.1.
3. Pharmaceutical form
Capsule, hard
Capsules with a red cap and green body, printed 'Lemsip' on the cap in
white ink, containing white, free
flowing powder.
4. Clinical particulars
4.1 Therapeutic indications
For the relief of symptoms of cold and influenza, including the relief
of aches and pains, sore throat,
headache, nasal congestion, lowering of temperature and chesty coughs.
4.2 Posology and method of administration
Adults (over 16 years and over): Two capsules every 4-6 hours to a
maximum of four doses in any 24
hours.
Do not exceed eight capsules in any 24 hours.
Children (12-15 years): One capsule every 4-6 hours to a maximum of
four doses in any 24 hours.
Do not exceed 4 capsules in any 24 hours.
Swallow whole with water. Do not chew.
Not recommended for children under 12 years of age.
4.3 Contraindications
Hypersensitivity to any of the ingredients. Severe coronary heart
disease and cardiovascular disorders.
Hypertension. Hyperthyroidism. Contraindicated in patients currently
receiving or within two weeks of
stopping therapy with monoamine oxidase inhibitors.
4.4 Special warnings and precautions for use
Use with caution in patients with Raynaud's phenomenon or diabetes
mellitus. Care is advised in the
administration of paracetamol to patients with severe renal or severe
hepatic impairment. The hazard of
overdose is greater in those with non-cirrhotic alcoholic liver
disease. Do not take with any other
paracetamol-containing products.
Phenylephrine should be used with care in patients with closed angle
glaucom